CTOs on the Move

Physicians Choice Home Health

www.pchhc.com

 
Physicians Choice Home Health is a Torrance, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.pchhc.com
  • 3625 Del Amo Blvd Ste 390
    Torrance, CA USA 90503
  • Phone: 310.793.1616

Executives

Name Title Contact Details

Similar Companies

American Indian Health and Svc

American Indian Health and Svc is a Santa Barbara, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Chapters Health

“We are a part of the circle of life. It`s as touching and important to be a part of the end of life as it is to be at the beginning. We provide our patients dignity, comfort and quality of life at the end of their journey. Our job is so much more about life than death! Being present during this sacred time is truly and honor, a calling. “ -Jane, LPH Registered Nurse **** Chapters Health System is committed to enhancing the lives of those affected by advancing age or illness. Through our comprehensive system of healthcare choices, we deliver expert care and heartfelt support to guide the community during the aging and end-of-life journey. From hospice and palliative care for adults and children suffering with life-threatening or life-limiting illnesses to in-home and community-based services for frail but independent seniors, Chapters Health offers a wide range of support services along life`s ever-changing landscape. By providing choices, education and guidance, Chapters Health helps enhance the lives of those affected by advancing age or illness. Chapters Health System includes Chapters Health Palliative Care, Chapters Health Pharmacy, Chapters Health Staffing, Good Shepherd Hospice, HPH Home Health, HPH Hospice and LifePath Hospice.

Portola

Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.

Let Medical Systems

Let Medical Systems is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Defend MyDent International

Defend MyDent International is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.